You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, May 28, 2020 /PRNewswire/ -- The "COVID-19 Drug and Vaccine Pipeline Current Status Report: May 2020 Update" report has been added to ResearchAndMarkets.com's offering. The COVID-19 pipeline report presents the most recent updates on drug candidates and vaccine candidates that will potentially reach the market in the next 2 years. As of May 2020, the COVID-19 pipeline remains robust with over 150 therapeutic and Vaccine candidates under development. 150 companies including large scale and small scale companies are participating in the development of treatment and vaccination against novel corona virus infected COVID-19. The report provides complete details of pipeline drugs including the development phase, companies involved, clinical trial developments, and other details. Further, the report also provides COVID-19 drug development history, latest news, and other developments. Report Snapshot COVID-19 pipeline comprises of 153 drug candidates under development as of April 2020. The pipeline is characterized by the presence of both large scale companies and small players. Large companies including Novartis, Pfizer, Zydus, Roche, Sanofi and GlaxoSmithKline continue to invest in treatment options vaccination candidates. Among pre-clinical and research phase candidates, several companies are looking for partnering with other companies or universities to advance their research studies. Interleukin 6 inhibitors' is among the most researched types in the pipeline. Around 77 of 153 candidates are new molecular entities. Of the 153 drug candidates in development, 10 drug/vaccine candidates advanced to Phase 3 while 13 candidates are in Phase 2. Five candidates are in Phase 1 and 42 candidates are in the preclinical study phase. Further, the number of drug and vaccine candidates in the research study phase stood at 83. Report Scope 153 drugs and vaccines, 150+ companies covered New molecular entities identified Pre-clinical, research, clinical-stage products analyzed Drug, Mechanism of Action, Phase, Co-Developer, Originator, Synonyms, Route of Administration, New Molecular Entity details provided Further, Current Status, Drug details, trial details are provided Latest market and pipeline developments are provided in the report Key Topics Covered 1 Executive Summary 1.1 Disease Overview 1.2 Pipeline Snapshot 1.3 Pipeline Drugs by Phase 1.4 Pipeline Drugs by New Molecular Entity 1.5 Pipeline Drugs by Mechanism of Action 2 Phase 3 COVID-19 Drug Candidates in Active Development 2.1 AstraZeneca Plc COVID-19 Pipeline 2.2 Novartis AG COVID-19 Pipeline 2.3 Gilead Sciences Inc COVID-19 Pipeline 2.4 FUJIFILM Toyama Chemical Co. Ltd COVID-19 Pipeline 2.5 Vanda Pharmaceuticals Inc COVID-19 Pipeline 2.6 Roche AG COVID-19 Pipeline 2.7 OncoImmune Inc COVID-19 Pipeline 2.8 Sanofi SA COVID-19 Pipeline 2.9 Swedish Orphan Biovitrum AB COVID-19 Pipeline 2.10 CytoDyn Inc COVID-19 Pipeline 3 Phase 2 COVID-19 Drug Candidates in Active Development 3.1 Eli Lilly and Company COVID-19 Pipeline 3.2 Karyopharm Therapeutics Inc COVID-19 Pipeline 3.3 Synairgen Plc COVID-19 Pipeline 3.4 Bristol-Myers Squibb Co. COVID-19 Pipeline 3.5 Tianjin CanSino Biotechnology COVID-19 Pipeline 3.6 Kinevant Sciences Ltd COVID-19 Pipeline 3.7 Vitaeris Inc COVID-19 Pipeline 3.8 Relief Therapeutics Holdings COVID-19 Pipeline 3.9 Viriom Inc COVID-19 Pipeline 3.10 CalciMedica Inc COVID-19 Pipeline 3.11 Apeiron Biologics GmbH COVID-19 Pipeline 3.12 Ansun Biopharma Inc COVID-19 Pipeline 3.13 I-MAB Biopharma Co Ltd COVID-19 Pipeline 4 Phase 1 COVID-19 Drug Candidates in Active Development 4.1 Moderna Therapeutics Inc COVID-19 Pipeline 4.2 Ridgeback Biotherapeutics LP COVID-19 Pipeline 4.3 BioCryst Pharmaceuticals Inc COVID-19 Pipeline 4.4 Inovio Pharmaceuticals Inc COVID-19 Pipeline 4.5 InflaRx NV COVID-19 Pipeline 5 Pre-Clinical COVID-19 Drug Candidates in Active Development 5.1 AIM ImmunoTech Inc COVID-19 Pipeline 5.2 Arcturus Therapeutics Holdings Inc COVID-19 Pipeline 5.3 ARMS Pharmaceutical LLC COVID-19 Pipeline 5.4 Mateon Therapeutics Inc COVID-19 Pipeline 5.5 Beyond Air Inc COVID-19 Pipeline 5.6 BioNTech SE COVID-19 Pipeline 5.7 Can-Fite Biopharma Ltd COVID-19 Pipeline 5.8 Clover Biopharmaceuticals COVID-19 Pipeline 5.9 Cocrystal Pharma Inc COVID-19 Pipeline 5.10 Eiger BioPharmaceuticals Inc COVID-19 Pipeline 5.11 Eli Lilly and Company COVID-19 Pipeline 5.12 Ennaid Therapeutics LLC COVID-19 Pipeline 5.13 Epitopoietic Research Corporation COVID-19 Pipeline 5.14 EpiVax Inc COVID-19 Pipeline 5.15 eTheRNA Immunotherapies NV COVID-19 Pipeline 5.16 FibroGenesis COVID-19 Pipeline 5.17 GigaGen Inc COVID-19 Pipeline 5.18 Heat Biologics Inc COVID-19 Pipeline 5.19 IBio Inc COVID-19 Pipeline 5.20 Immunic Inc COVID-19 Pipeline 5.21 IMV Inc COVID-19 Pipeline 5.22 INTELLiSTEM Technologies Inc COVID-19 Pipeline 5.23 Medicago Inc COVID-19 Pipeline 5.24 MedinCell S.A. COVID-19 Pipeline 5.25 BioSig Technologies Inc COVID-19 Pipeline 5.26 Novavax Inc COVID-19 Pipeline 5.27 OyaGen Inc COVID-19 Pipeline 5.28 PDS Biotechnology Corporation COVID-19 Pipeline 5.29 Primmune Therapeutics COVID-19 Pipeline 5.30 SAB Biotherapeutics COVID-19 Pipeline 5.31 Shanghai Junshi Biosciences COVID-19 Pipeline 5.32 Sorrento Therapeutics Inc COVID-19 Pipeline 5.33 Stabilitech Biopharma Ltd COVID-19 Pipeline 5.34 Starpharma Holdings Limited COVID-19 Pipeline 5.35 Stemirna Therapeutics Co Ltd COVID-19 Pipeline 5.36 Tonix Pharmaceuticals Holding Corp. COVID-19 Pipeline 5.37 Vaxart Inc COVID-19 Pipeline 5.38 VBI Vaccines COVID-19 Pipeline 5.39 Vir Biotechnology Inc COVID-19 Pipeline 5.40 Zydus Cadila COVID-19 Pipeline 6 Research COVID-19 Drug Candidates in Active Development 6.1 48Hour Discovery Inc 6.2 AbCellera Biologics Inc 6.3 Active Motif 6.4 Adaptive Biotechnologies Inc 6.5 AdaptVac 6.6 Airway Therapeutics Inc 6.7 AJ Vaccines 6.8 Akers Biosciences Inc 6.9 Akshaya Bio Inc6.10 Alkido Pharma Inc6.11 Altimmune Inc6.12 Amarillo Biosciences Inc6.13 Array BioPharma Inc6.14 Axon Neuroscience SE6.15 Beroni group6.16 Biocad6.17 Bioxytran Inc6.18 Bold Therapeutics Inc6.19 Cell-Point LLC6.20 Celltrion Inc6.21 CEL-SCI Corporation6.22 Cobra Biologics Ltd6.23 Codagenix Inc6.24 CureVac AG6.25 Cytovia Therapeutics6.26 Dyadic International Inc6.27 Emergent BioSolutions Inc6.28 Entos Pharmaceuticals Inc6.29 EpiVax Inc6.30 Exscientia Ltd6.31 Generex Biotechnology Corporation6.32 GeoVax Labs6.33 Grifols SA6.34 HaloVax LLC6.35 Hetero Labs6.36 ImmunityBio Inc6.37 ImmunoPrecise Antibodies Ltd6.38 Imophoron Ltd6.39 Innovation Pharmaceuticals Inc6.40 Iontas6.41 IVIEW Therapeutics Inc6.42 Kali-extracts Inc6.43 Kamada Ltd6.44 Kleo Pharmaceuticals Inc6.45 Ligandal Inc6.46 LineaRx Inc6.47 Mabpharm Ltd6.48 Mateon Therapeutics Inc6.49 NanoViricides Inc6.50 Nascent Biotech Inc6.51 Neurimmune AG6.52 NuGenerex Immuno-Oncology Inc6.53 OliX Pharmaceuticals Inc6.54 Ology Bioservices Inc6.55 OncoSec Medical Inc6.56 Pfizer Inc6.57 Pneumagen Ltd6.58 Q BioMed Inc6.59 Qurient Co Ltd6.60 Regeneron Pharmaceuticals Inc6.61 Resverlogix Corp6.62 Sanofi SA6.63 Sirnaomics Inc6.64 Sirona Biochem Corp6.65 SmartPharm Therapeutics Inc6.66 Soligenix Inc6.67 Sorrento Therapeutics Inc6.68 Sosei Group Corporation6.69 Takeda Pharmaceutical Company Ltd6.70 Takis Biotech6.71 Themis Bioscience GmBH6.72 Ufovax Inc6.73 United Biomedical Inc6.74 Vanda Pharmaceuticals Inc6.75 Vaxil BioTherapeutics Ltd6.76 Vir Biotechnology Inc6.77 Viravaxx AG6.78 WuXi Biologics Inc6.79 XORTX Therapeutics Inc For more information about this report visit https://www.researchandmarkets.com/r/kdc1rv Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: COVID-19 Drug and Vaccine Pipeline Overview, 2020 - 153 Drugs and Vaccines Presented, 150+ Companies Covered